News Headlines Article

Alzheimer’s startup lands $37.5 million investment
San Francisco Business Times

A Stanford University spinout targeting Alzheimer’s disease landed a $37.5 million investment from Spanish drug maker Grifols S.A.

Alkahest, launched last year by Stanford professor Tony Wyss-Coray, is aimed at infusing Alzheimer’s patients with plasma from young people. It is one of the first tenants in Johnson & Johnson’s new biotech incubator in South San Francisco. Grifols’ investment is for a 45 percent stake in Alkahest, whose other investors include Bioville Investment Ltd., Full House Investment Ltd. and Stanford.